Armando E. Giuliano

Active 1979–2025

139
Papers
35,693
Citations
89
h-index
137
i10-index

Citations

Citations per year for Armando E. Giuliano1974: 1 citations1981: 5 citations1982: 1 citations1987: 1 citations1991: 1 citations1992: 1 citations1994: 1 citations1995: 3 citations1996: 8 citations1997: 28 citations1998: 76 citations1999: 117 citations2000: 142 citations2001: 235 citations2002: 145 citations2003: 172 citations2004: 154 citations2005: 171 citations2006: 161 citations2007: 176 citations2008: 223 citations2009: 202 citations2010: 222 citations2011: 256 citations2012: 236 citations2013: 259 citations2014: 213 citations2015: 226 citations2016: 163 citations2017: 181 citations2018: 196 citations2019: 748 citations2020: 743 citations2021: 715 citations2022: 501 citations2023: 341 citations2024: 633 citations2025: 280 citations2026: 10 citations1975–1980: no citations, so these years are not shown1983–1986: no citations, so these years are not shown1988–1990: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,321 citing papers, 28.5% of this breakdownChina: 943 citing papers, 11.6% of this breakdownUnited Kingdom: 434 citing papers, 5.3% of this breakdownItaly: 433 citing papers, 5.3% of this breakdownGermany: 384 citing papers, 4.7% of this breakdownNetherlands: 313 citing papers, 3.8% of this breakdownFrance: 242 citing papers, 3% of this breakdownCanada: 238 citing papers, 2.9% of this breakdownJapan: 197 citing papers, 2.4% of this breakdownSpain: 183 citing papers, 2.2% of this breakdownAustralia: 180 citing papers, 2.2% of this breakdownSouth Korea: 177 citing papers, 2.2% of this breakdown
0%28.5%Other 25.9%

Fields

  • Biochemistry, Genetics and Molecular Biology53.9%
  • Medicine38.1%
  • Engineering2.2%
  • Computer Science1.6%
  • Immunology and Microbiology1.4%
  • Materials Science0.7%
  • Other2.1%

Topics

  • Breast Cancer Treatment Studies13.3%
  • Breast Lesions and Carcinomas8.3%
  • Breast Implant and Reconstruction6.2%
  • Cancer Cells and Metastasis3.6%
  • Cancer Genomics and Diagnostics2.3%
  • Lymphatic System and Diseases2.2%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

    Authors: , , , , , , , , , , , , , - JAMA 2017 cited by 1,862

  2. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Negin Habibi Khameneh, Heather L. McArthur, Simon Knott - Cancer Cell 2024 cited by 164

  3. Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    Authors: , , , , , , , , - CA A Cancer Journal for Clinicians 2017 cited by 977

  4. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

    Authors: - JAMA 2011 cited by 2,924

  5. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer

    Authors: , , - Annals of Surgical Oncology 2018 cited by 666

  6. Breast cancer lung metastasis: Molecular biology and therapeutic implications

    Authors: , , , , , - Cancer Biology & Therapy 2018 cited by 303

  7. Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2007 cited by 911

  8. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: , , , , , - Journal of Clinical Oncology 2017 cited by 591

  9. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 1,893

  10. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

    Authors: , , , , , , , , , - Annals of Surgery 2010 cited by 1,254

  11. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,029

  12. Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Syed Nabeel Zafar, Vibhavari Naik, Lisa A. Newman, Alexandre Ferreira Oliveira, Do Joong Park, C.S. Pramesh, Saieesh Rao, T. Subramanyeshwar Rao, Enrique Bargalló‐Rocha, Anya Romanoff, Anne F. Rositch, Isabel T. Rubio, Héber Salvador de Castro Ribeiro, Eman Sbaity, Maheswari Senthil, Lynette M. Smith, Masakazi Toi, Kiran K. Turaga, Ujwal Yanala, Cheng Har Yip, Ashraf Zaghloul, Benjamin O. Anderson - The Lancet Oncology 2023 cited by 87

  13. Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial

    Authors: , , , , , , , , , , , - Annals of Surgical Oncology 2006 cited by 581

  14. Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

    Authors: , , , , , , , - PLoS ONE 2015 cited by 299

  15. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer

    Authors: , , , - Annals of Surgery 1994 cited by 2,918

  16. Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention Nutrition Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2006 cited by 823

  17. Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 cited by 118

  18. Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

    Authors: , , , , , , , - Journal of Clinical Oncology 2014 cited by 392

  19. Critical protein GAPDH and its regulatory mechanisms in cancer cells.

    Authors: , , , , , , , - 2015 cited by 202

  20. B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis

    Authors: , , , , , , , - Annals of Surgery 2010 cited by 149

  21. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

    Authors: , , , , , , , , , , , - Annals of Surgical Oncology 2014 cited by 611

  22. Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer

    Authors: , , , , , - Clinical Chemistry 2010 cited by 450

  23. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , - 2020 cited by 216

  24. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 74